Association of prostate cancer risk alleles with unfavourable pathological characteristics in potential candidates for active surveillance

BJU International

Volumn 110, Issue 3, 2012, Pages 338-343

  McGuire, Barry B ^a   Helfand, Brian T ^a   Kundu, Shilajit ^a   Hu, Qiaoyan ^a   Banks, Jessica A ^a   Cooper, Phillip ^a   Catalona, William J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

active surveillance; prostate cancer; risk allele; single nucleotide polymorphism

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ALLELE; ARTICLE; CANCER RISK; CONTROLLED STUDY; ETHNIC GROUP; EUROPEAN; GENETIC ASSOCIATION; GENOTYPE; GLEASON SCORE; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RECEIVER OPERATING CHARACTERISTIC; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; ALLELES; CHROMOSOMES, HUMAN; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MALE; MIDDLE AGED; PATIENT SELECTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS; RISK FACTORS; WATCHFUL WAITING;

EID: 84863723931     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2011.10750.x     Document Type: Article

References (27)

1. Klotz LH, Choo R, Morton G, Danjoux C,. Expectant management with selective delayed intervention for favorable-risk prostate cancer. Can J Urol 2002; 9 (Suppl. 1): 2-7
2. Klotz L, Zhang L, Lam A, Nam R, Mamedov A, Loblaw A,. Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. J Clin Oncol 2010; 28: 126-31
3. Soloway MS, Soloway CT, Eldefrawy A, Acosta K, Kava B, Manoharan M,. Careful selection and close monitoring of low-risk prostate cancer patients on active surveillance minimizes the need for treatment. Eur Urol 2010; 58: 831-5
4. Savage CJ, Lilja H, Cronin AM, Ulmert D, Vickers AJ,. Empirical estimates of the lead time distribution for prostate cancer based on two independent representative cohorts of men not subject to prostate-specific antigen screening. Cancer Epidemiol Biomarkers Prev 2010; 19: 1201-7
5. Cooperberg MR, Broering JM, Carroll PR,. Time trends and local variation in primary treatment of localized prostate cancer. J Clin Oncol 2010; 28: 1117-23
6. Lindstrom S, Schumacher F, Siddiq A, et al,. Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers-results from BPC3. PLoS ONE 2011; 6: e17142
7. Zheng SL, Sun J, Wiklund F, et al,. Cumulative association of five genetic variants with prostate cancer. N Engl J Med 2008; 358: 910-9 (Pubitemid 351397090)
8. Thomas G, Jacobs KB, Yeager M, et al,. Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet 2008; 40: 310-5 (Pubitemid 351311773)
9. Carter HB, Kettermann A, Warlick C, et al,. Expectant management of prostate cancer with curative intent: an update of the Johns Hopkins experience. J Urol 2007; 178: 2359-65 (Pubitemid 350052183)
10. Amundadottir LT, Sulem P, Gudmundsson J, et al,. A common variant associated with prostate cancer in European and African populations. Nat Genet 2006; 38: 652-8 (Pubitemid 43927306)
11. Helfand BT, Fought AJ, Loeb S, Meeks JJ, Kan D, Catalona WJ,. Genetic prostate cancer risk assessment: common variants in 9 genomic regions are associated with cumulative risk. J Urol 2010; 184: 501-5
12. Thaxton CS, Loeb S, Roehl KA, Kan D, Catalona WJ,. Treatment outcomes of radical prostatectomy in potential candidates for 3 published active surveillance protocols. Urology 2010; 75: 414-8
13. Mufarrij P, Sankin A, Godoy G, Lepor H,. Pathologic outcomes of candidates for active surveillance undergoing radical prostatectomy. Urology 2010; 76: 689-92
14. Griffin CR, Yu X, Loeb S, et al,. Pathological features after radical prostatectomy in potential candidates for active monitoring. J Urol 2007; 178 (3 Pt 1): 860-3 (Pubitemid 47224947)
15. Suardi N, Briganti A, Gallina A, et al,. Testing the most stringent criteria for selection of candidates for active surveillance in patients with low-risk prostate cancer. BJU Int 2010; 105: 1548-52
16. Lichtenstein P, Holm NV, Verkasalo PK, et al,. Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000; 343: 78-85 (Pubitemid 30451850)
17. Ding Z, Wu CJ, Chu GC, et al,. SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression. Nature 2011; 470: 269-73
18. Cheng I, Plummer SJ, Jorgenson E, et al,. 8q24 and prostate cancer: association with advanced disease and meta-analysis. Eur J Hum Genet 2008; 16: 496-505 (Pubitemid 351420383)
19. Camp NJ, Farnham JM, Wong J, Christensen GB, Thomas A, Cannon-Albright LA,. Replication of the 10q11 and Xp11 prostate cancer risk variants: results from a Utah pedigree-based study. Cancer Epidemiol Biomarkers Prev 2009; 18: 1290-4
20. Helfand BT, Loeb S, Cashy J, et al,. Tumor characteristics of carriers and noncarriers of the deCODE 8q24 prostate cancer susceptibility alleles. J Urol 2008; 179: 2197-202
21. Helfand BT, Loeb S, Meeks JJ, Fought AJ, Kan D, Catalona WJ,. Pathological outcomes associated with the 17q prostate cancer risk variants. J Urol 2009; 181: 2502-7
22. Helfand BT, Loeb S, Kan D, Catalona WJ,. Number of prostate cancer risk alleles may identify possibly 'insignificant' disease. BJU Int 2010; 106: 1602-6
23. Gudmundsson J, Sulem P, Manolescu A, et al,. Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat Genet 2007; 39: 631-7 (Pubitemid 46676102)
24. Tan YC, Zeigler-Johnson C, Mittal RD, et al,. Common 8q24 sequence variations are associated with Asian Indian advanced prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2008; 17: 2431-5
25. Pal P, Xi H, Guha S, et al,. Common variants in 8q24 are associated with risk for prostate cancer and tumor aggressiveness in men of European ancestry. Prostate 2009; 69: 1548-56
26. Hawksworth D, Ravindranath L, Chen Y, et al,. Overexpression of C-MYC oncogene in prostate cancer predicts biochemical recurrence. Prostate Cancer Prostatic Dis 2010; 13: 311-5
27. Zheng SL, Sun J, Cheng Y, et al,. Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans. J Natl Cancer Inst 2007; 99: 1525-33 (Pubitemid 351767236)